Cerebral metabolism and risperidone treatment in schizophrenia

Andreasen, 1996, PET and the [15O]H2O technique: Part 2. Choosing a significance threshold, Am. J. Psychiatry, 153, 6, 10.1176/ajp.153.1.6 Andreasen, 1994, Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging, Science, 266, 294, 10.1126/science.7939669 Andreasen, 1997, Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naı̈ve patients, Lancet, 349, 1730, 10.1016/S0140-6736(96)08258-X Bartlett, 1994, Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects, Am. J. Psychiatry, 151, 681, 10.1176/ajp.151.5.681 Berman, 1996, Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study, Psychopharmacol. Bull., 32, 95 Breier, 1999, Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response, Am. J. Psychiatry, 156, 294, 10.1176/ajp.156.2.294 Buchsbaum, 1987, Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients, Biol. Psychiatry, 22, 479, 10.1016/0006-3223(87)90170-3 Buchsbaum, 1996, PET and MRI of the thalamus in never-medicated patients with schizophrenia, Am. J. Psychiatry, 153, 191, 10.1176/ajp.153.2.191 Chouinard, 1998, Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia, Can. J. Psychiatry, 43, 1018, 10.1177/070674379804301007 Clow, 1980, Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration, Eur. J. Pharmacol., 63, 145, 10.1016/0014-2999(80)90438-0 Cohen, 1997, The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task, Arch. Gen. Psychiatry, 54, 481, 10.1001/archpsyc.1997.01830170107014 Davies, 1998, Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety, Clin. Ther., 20, 58, 10.1016/S0149-2918(98)80034-9 DeLisi, 1985, Positron emission tomography in schizophrenic patients with and without neuroleptic medication, J. Cereb. Blood Flow Metab., 5, 201, 10.1038/jcbfm.1985.26 Efron, 1986, Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy, Stat. Sci., 1, 54, 10.1214/ss/1177013815 Fox, 1970, The caudate nucleus-cerebellar pathways: an electrophysiological study of their route though the midbrain, Brain Res., 20, 144 Frackowiak, 1997 Holcomb, 1996, Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol, Am. J. Psychiatry, 153, 41, 10.1176/ajp.153.1.41 Javitt, 1993, Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study, Biol. Psychiatry, 33, 513, 10.1016/0006-3223(93)90005-X Kim, 2000, Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography, Am. J. Psychiatry, 157, 542, 10.1176/appi.ajp.157.4.542 Lahti, 1995, Ketamine activates psychosis and alters limbic blood flow in schizophrenia, NeuroReport, 6, 869, 10.1097/00001756-199504190-00011 Lewis, 1992, A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia, Psychol. Med., 22, 27, 10.1017/S0033291700032694 Liddle, 2000, Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus, Br. J. Psychiatry, 177, 402, 10.1192/bjp.177.5.402 Miller, 2001, Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia, Biol. Psychiatry, 49, 704, 10.1016/S0006-3223(00)01001-5 Molina Rodriguez, 1997, Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study, Schizophr. Res., 25, 11, 10.1016/S0920-9964(96)00115-6 Mufson, 1984, Thalamic connections of the insula in the rhesus monkey and comments on the paralimbic connectivity of the medial pulvinar nucleus, J. Comp. Neurol., 227, 109, 10.1002/cne.902270112 Pakkenberg, 1992, The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics, Schizophr. Res., 7, 95, 10.1016/0920-9964(92)90038-7 Poline, 1997, Combining spatial extent and peak intensity to test for activations in functional imaging, Neuroimage, 5, 83, 10.1006/nimg.1996.0248 Potkin, 1994, Clozapine effects on glucose metabolic rate in striatum and frontal cortex, J. Clin. Psychiatry, 55, 63 Robertson, 1992, Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine, Neuroscience, 46, 315, 10.1016/0306-4522(92)90054-6 Steriade, 1997, Thalamic organization and chemical anatomy, vol. I, 150 Talairach, 1998 Tamminga, 1999, Glutamatergic aspects of schizophrenia, Br. J. Psychiatry Suppl., 12, 10.1192/S0007125000293598 Tauscher, 1999, In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol, Psychopharmacology (Berlin), 141, 175, 10.1007/s002130050822 Vita, 1995, High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients, Am. J. Psychiatry, 152, 876, 10.1176/ajp.152.6.876 Young, 2000, Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia, Biol. Psychiatry, 47, 944, 10.1016/S0006-3223(00)00826-X